AZLIN Drug Patent Profile
✉ Email this page to a colleague
When do Azlin patents expire, and what generic alternatives are available?
Azlin is a drug marketed by Bayer Pharms and is included in three NDAs.
The generic ingredient in AZLIN is azlocillin sodium. Additional details are available on the azlocillin sodium profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for AZLIN?
- What are the global sales for AZLIN?
- What is Average Wholesale Price for AZLIN?
Summary for AZLIN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 43 |
Patent Applications: | 4,731 |
DailyMed Link: | AZLIN at DailyMed |
US Patents and Regulatory Information for AZLIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bayer Pharms | AZLIN | azlocillin sodium | INJECTABLE;INJECTION | 062388-001 | Sep 8, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Bayer Pharms | AZLIN | azlocillin sodium | INJECTABLE;INJECTION | 062388-003 | Sep 8, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Bayer Pharms | AZLIN | azlocillin sodium | INJECTABLE;INJECTION | 062388-002 | Sep 8, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Bayer Pharms | AZLIN | azlocillin sodium | INJECTABLE;INJECTION | 062417-003 | Oct 12, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Bayer Pharms | AZLIN | azlocillin sodium | INJECTABLE;INJECTION | 062417-001 | Oct 12, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |